DNA Methylation Signatures Identify Biologically Distinct Thyroid Cancer SubtypesSandra Rodríguez‐Rodero, Mario F. Fraga, Gustavo F. Bayón et al.|The Journal of Clinical Endocrinology & Metabolism|2013Cited by 122
CDK7-targeted therapy effectively disrupts cell cycle progression and oncogenic signaling in head and neck cancerMaría Otero‐Rosales, Francisco Hermida‐Prado, Miguel Álvarez-González et al.|Signal Transduction and Targeted Therapy|2025Cited by 2